Background Percutaneous osseointegrated prosthetic (POP) devices have been used clinically in Europe for decades. Unfortunately, their introduction into the United States has been delayed, in part due to the lack of data documenting the progression of osseointegration and mechanical stability.
Introduction
Socket suspension of exoprostheses is the current standard for amputee care but is far from ideal for many patients. This approach commonly fails in patients with multiple limb loss or short residual limbs [51, 52] . Even patients considered successful users of socket suspension frequently experience pain from continued soft tissue compromise resulting from changing or poor socket fit [18, 21, 22, 29, 45, 46] . Particularly in the military population, blast-related heterotopic ossification (refers as bone formation at an abnormal anatomic sites) within the soft tissues of the residual limb can make successful socket fitting difficult or impossible [34, 50, 51] . Because these limitations significantly impair the quality of life for a large percentage of amputees, percutaneous osseointegrated prosthetic (POP) suspension devices are currently being investigated.
As early as the 1940s, clinician-scientists tried to circumvent the problems of socket suspension with attempts at percutaneous skeletal exoprosthetic docking, and an intramedullary, stainless steel attachment device was cemented in the residual stump bone of lower-extremity amputees [25, 48] . In this small group of patients, early soft tissue infections resulted in device removal before the bony stability of the endoprosthesis could be determined [48] . In the 1970s, Mooney et al. [47] again used bone cement to attach a stainless steel endoprostheses with a carbon collar into three aboveelbow amputees. All of the implants failed due to infection and were removed after 6 months. Once again, infection prevented assessment of the stability of the device in the bone. In the late 1960s, Per-Ingvar Brånemark [11] reported that living bone formed a bond with devices fabricated from titanium. Termed osseointegration, this phenomenon allows bony attachment to implanted devices without the use of bone cement to create a bond between device and bone. Implants designed to achieve osseointegration (attachment) with the living bone have been widely used in hip and knee arthroplasty for decades. This attachment technology is now being utilized for POP devices for amputees [11] [12] [13] 30] .
Since the 1990s, three groups throughout Europe have tried a variety of POP devices for patients with limb loss [1, 11-13, 30, 33, 42] . Early results suggest that POP devices can improve the quality of life for patients by increasing the time of exoprosthesis use per day [26, 33] , facilitating faster doffing and donning of the exoprosthesis [31, 33] , improving gait [26] , and providing proprioceptive sensation to the residual limb known as osseoperception [32] . The primary limitation to the widespread use of POP devices has been the potential for periprosthetic infections [57, 58] . However, recent advances using porous subdermal barriers to limit infections have greatly reduced this problem [38, 41] . The relative ability of these human POP device surfaces to become osseointegrated remains poorly understood, and for obvious reasons, the rate at which they do so is impossible to document in the human implant situation. These uncertainties lead to questions, including when does the device actually become mechanically stable in the bone and when can postoperative weightbearing safely begin?
The purpose of this study was to determine the progression of bone ingrowth into porous-coated POP devices and to establish the interrelationship with mechanical stability in a translational animal model. Using an axially weightbearing large-animal model, we specifically sought to (1) measure the progression of bone ingrowth into the porous coating of the POP device, (2) evaluate the progression of mechanical stability (ie, resistance pullout) over a 1-year period of bone ingrowth, and (3) determine the relationship between the amount of ingrowth and mechanical stability.
Materials and Methods

POP Device Design
An intramedullary endoprosthetic device (Thortex Inc, Portland, OR, USA) was developed to fit the medullary canal of the fused metacarpal III/IV bone of sheep ( Fig. 1A ) and has been described in our previous publications [41, 55] . Regions 3 and 4 ( Fig. 1B) of the device had a porous titanium coating, a proprietary pure titanium coating (P 2 ; DJO Global, Vista, CA, USA) ( Fig. 2) .
Surgery
Sixty-four female and male mixed-breed sheep (2-5 years of age), with a mean body mass of 88 ± 12 kg, were used in this study from a cohort of 86 animals. Sheep were randomly separated into five experimental groups according to time of euthanasia: Time 0 (n = 11), 3 months (n = 14), 6 months (n = 14), 9 months (n = 14), and 12 months (n = 11). Randomization of the animals was not stratified by sex. Following institutionally approved animal use protocols of the US Department of Defense, Salt Lake City Veterans Affairs, and Innovative Medical Device Solution Discovery Research (Logan, UT, USA), the POP device (both endo-and exoprosthetic components) was implanted into the right amputated forelimb of each animal under sterile conditions [41] .
This study was part of a larger study, where 86 sheep were used to test various aspects of the POP device's performance [38, 40, 41, 55] .
Postoperative Animal Care
After skin closure, the operative site was protected with a dressing and the animals were kept indoors in temperature-controlled pens for the first 14 days. For the remainder of the study, animals were housed outside in a covered paddock with hay flooring. Full weightbearing was allowed as tolerated immediately after the surgery. Limb function was frequently evaluated by either trained animal care technicians or a veterinary surgeon, which was based on subjective observations of lameness and clinical signs of infection [15] . As an objective measure, monthly gait measurement was also taken from a subset of these sheep and reported elsewhere [55] . The skin neighboring the percutaneous portion of the device was then cleaned weekly and sprayed with PureWorks 1 antiseptic spray (benzethonium chloride; Pure Works, LLC, Farmington, UT, USA).
End Point Criteria
Sheep were euthanized when infected at a Grade 3 on the modified Checketts scale [15] or at predetermined time periods of 0, 3, 6, 9, and 12 months. Euthanasia was performed in accordance with the American Veterinary Medical Association guidelines. At necropsy, each group of animals was randomly subgrouped for histologic (n = 32) and pullout strength (n = 32) evaluations. The POP devices with surrounding tissues were harvested en bloc.
Histologic Evaluations
All histologic specimens were fixed using 10% formalin buffer for 7 days, followed by dehydration in successive concentrations of ethanol. The specimens were then infiltrated and embedded in polymethylmethacrylate, sectioned, and ground and polished to an optical finish, as described in our previous publications [38, 40, 41] .
The host bone tissues were separated into three regions (porous coated, fluted, and smooth) corresponding to the surface morphologies of the intramedullary device ( Fig. 1B ) Fig and the porous-coated region (n = 3) was used for the ingrowth analysis presented in this study. Polished sections were carbon coated for 25 seconds and evaluated for the percentage of bone present within the pores. Each section was examined in a scanning electron microscope (SEM) (JSM 6100; JEOL Inc, Peabody, MA, USA) by using the backscattered electron (BSE) detector (JEOL-64090BEIW; JOEL Inc) at 920 and 9100 magnifications. The amount of bone present within the porous coating was calculated by using gray-scale threshold values, with values of 0 to 5 representing the pores (black), 6 to 245 representing the bone tissue (gray), and 246 to 255 representing device material (white) (IQ Materials System, Version 2; Media Cybernetics, Bethesda, MD, USA) [54] . The percentage of bone within the porous-coated region was represented as the area occupied by bone as a fraction of available pore spaces. Polished 50-to 70-lm-thick sections of boneimplant interfaces were stained with a solution of Sanderson's Rapid Bone Stain TM (Dorn and Hart Microedge, Villa Park, IL, USA) with acid fuchsin, counterstain (Surgipath Medical Industries, Inc., Richmond, IL, USA).
Axial Pullout Strength
All mechanical testing specimens were wrapped in salinesoaked gauze, refrigerated, and transported to the Orthopaedic Research Laboratory, University of Utah. To grip the POP device for axial pullout testing, a 0.5-inch-diameter hole was drilled through the subdermal barrier just proximal to the Morse taper of the POP device. Within the cortical bone proximal to the device tip, drywall screws were placed perpendicular to the shaft, and it was then submerged in melted Cerrobend TM low-melt potting material (Scottsdale Tool, Phoenix, AZ, USA) in a custommade aluminum cylinder with a 5-inch (12.7-cm) diameter and 4-inch (10.2-cm) height. The Cerrobend TM potting compound was then cooled until it became solid. Each specimen was clamped (ensuring axial alignment) in place and a stainless steel rod was placed through the 0.5-inch (1.3-cm) diameter hole drilled through the POP device and connected to the actuator of a hydraulic material testing system (Model 8500; Instron Corp, Canton, MA, USA) ( Fig. 3) . The device was loaded uniaxially using displacement control at a constant rate (100 mm/minute) until ultimate failure of the bone-device interface occurred.
Statistical Analysis
Data are presented as mean ± SD. All statistical analyses were conducted using SPSS 1 software (Version 11.5; SPSS Inc, Chicago, IL, USA). For ingrowth and axial pullout strength, the 3-month data were compared to Time 0 and 6-month data, 6-month data were compared to 3-month and 9-month data, and 9-month data were compared to 6-month and 12-month data using independent-sample t-tests. The four p values were adjusted for multiple comparisons using the Hochberg's procedure [2] . All tests were two-tailed and conducted at a 5% significance level.
Results
There was a relatively accelerated bone ingrowth between 0 and 3 months ( Figs. 4, 5) , followed by a relatively gradual bone ingrowth period. At Time 0, the mean percentage of bone tissue within the porous coating was 5.5% ± 1.3%, which was attributed to bone chips impacted into the coating at the time of insertion. By 3 months, ingrowth data showed a *10-fold increase (*48% ± 15% of the area occupied by bone as a fraction of the total available pore spaces), which was further increased to *11-fold (*53% ± 14%) by 6 months, *12-fold (*64% ± 10%) by 9 months, and *14-fold (*71% ± 8%) by 12 months when compared to Time 0 values. The most accelerated ingrowth phase was between 0 and 3 months, and ingrowth continued, albeit more slowly, over the rest of the 12month study period (Fig. 5) .
In terms of mechanical attachment strength, we observed that it improved rapidly over the first 3 months and that more gradual changes were followed over the next 9 months of the study (Fig. 6 ). The pullout force data showed that the attachment improved with increasing device in situ time, from a mean of 988 ± 847 N measured at Time 0 to 5066 ± 1543 N at 3 months, to 9636 ± 1303 N at 6 months, to 10,347 ± 2417 N at 9 months, and to 13,485 ± 1626 N by 12 months (Fig. 6 ). The axial pullout force data followed a pattern similar to that of the ingrowth data ( Fig. 5) . When compared to Time 0 data, an initial fivefold increase in pullout force data within 3 months was further increased to approximately 14-fold progressively by the end of 1 year postsurgery (Fig. 6 ). However, it must be noted that there was a 50% increase in bone ingrowth between 3 and 12 months but a 166% increase in attachment strength at the same time points.
Increased ingrowth as demonstrated histologically was associated with increased mechanical stability of the POP device. We observed a positive, linear relationship between the amount of bone ingrowth into the porous-coated POP device and the resulting mechanical attachment (Fig. 7) . Plotting the mechanical pullout data as a function of the bone ingrowth data, we found a positive correlation (y = 166.74x; R = 0.94) between axial pullout strength and bone ingrowth.
Discussion
Although socket suspension of exoprostheses is the current standard of care, it is not successful for all amputees. POP devices are one alternative to socket systems and are under clinical investigation in Europe. Osseointegration has been used as a method of attaching these POP devices to the residual stump bone [1, 30, 42] , and different designs of POPs are currently used in these clinical trials. Because the required experimental techniques cannot be tested in humans, the progression of osseointegration and POP device stability has not been adequately studied and this has led to differences in clinical rehabilitation protocols for postoperative weightbearing. While few animal studies The data indicate an initial accelerated bone ingrowth phase within the porous-coated region between 0 and 3 months (p = 0.002), which was followed by moderately progressive bone ingrowth and a remodeling period of up to 12 months. n = 7 animals/group for all groups except for the Time 0 group (n = 5 animals). evaluated the relationship between osseointegration and mechanical stability of these devices [14, 19, 20] , to our knowledge, no studies have compared the attachment of bone to pullout strength. Moreover, data from small-animal studies, as previously tested, are difficult to translate to humans because of the rate of cortical bone remodeling of rats [16] , which has been shown to be eight times faster than that in humans [17, 44] . We therefore used a sheep model to determine the rate of bone ingrowth into porouscoated POP devices and the rate of mechanical resistance to pullout with POP devices and established the relationship between the amount of bone ingrowth and mechanical pullout strength.
There are limitations to this study. Although the pore sizes and porosity chosen in this study fall within the literature's recommended values [7] , additional studies, using the same animal model, could validate other porous-coating types or surfaces for human POP applications. In this weightbearing sheep model, nearly 48% of the pore space on the endoprostheses was filled with bone with a resulting pullout force of more than 5000 N within the first 3 months postimplantation. Human retrieval studies often show more than 10% pore fill at the same time period [3] . Currently, it is not known precisely how much bone ingrowth is adequate for clinical fixation of human POP devices, but it is noteworthy that, in this sheep model, bone kept growing into pores over the study period of 12 months. Testing the validity of the reported one-stage surgical protocol compared to the current two-stage surgery clinical practice in a translational model could have been beneficial, but obtaining an institutional approval to carry out such studies had proven impossible. Also, the gait distribution differs between bipedal humans and quadrupedal sheep, which limit the direct translation of the data to humans. Although the bone-healing response in sheep was similar to that of humans with secondary osteonal remodeling, initially a human amputee bone would likely be more osteopenic at implantation than sheep bone. The bone quality differences could contribute to the mechanical stability differences in human studies. Although rotational stability has significance for devices in the cylindrical human femoral canal, the sheep metacarpal canal is asymmetrical, nearly oval in cross section. Due to this geometrical restriction of the device, only pullout testing was performed, since the torsional testing would only have shattered the bone.
Other studies have demonstrated that the bone ingrowth into the porous coating can be an effective means of bonedevice fixation [4-6, 24, 43, 49, 56] . Similar to previously reported mineral apposition rate results [40] , the ingrowth data further validated that there were two distinct phases of bone remodeling: (1) a rapid bone ingrowth phase between 0 and 3 months and (2) a gradual bone ingrowth phase between 3 and 12 months. This ingrowth trend was also similar to data published for human bone tissue [35] and for sheep bone [38, 59] . Although these studies did not analyze their data in the same manner as we did, their data ( Fig. 5 [35] and Fig. 7 [59] ) clearly displayed the statistical differences between Time 0 and the 3-month time points. Moreover, similarities between this study and the previous human bone ingrowth data further supported the translational relevance of the sheep model used in this investigation [35, 59] .
The observed phases of bone ingrowth may be explained by the fundamental principles of bone healing and remodeling. The bone repair process was expected to be accelerated for a period of time after the surgical insult, possibly due to the stimuli for healing or increased bone turnover due to a described regional acceleratory phenomenon [27] . The initially accelerated bone ingrowth phase has therefore been attributed to the regional acceleratory phenomenon, the injury response to the surgical trauma and implant insertion. This appears to be in line with the observations of other researchers, who also have attributed the early increase in bone apposition or ingrowth to the regional acceleratory phenomenon [36, 37, 60] . During the 3-month accelerated bone ingrowth phase, newly formed bone filled approximately 48% of total available pore space of the P 2 structure, increasing the stability of the device. This phase was then followed by a slower gradual bone ingrowth phase, possibly due to the mechanical and bone adaptation responses stimulated by the direct weightbearing forces transmitted from the implant to the endosteal wall. As a result, an additional 20% (as a percentage of total available pore spaces) of bone tissue was deposited between the 3-and 12-month periods.
The mechanical axial pullout measurements were used in this study to assess the relationship between skeletal attachment by bone ingrowth and the mechanical attachment strength of the POP devices. Although it is well established that bone will infiltrate different pore sizes (20-1000 lm) of an inert porous device system [8, 23, 56] , pore sizes of greater than 150 lm have been reported to be required for osteon formation [39] . As seen in this study, the osteons were observed not only in the larger pores of the P 2 coating (257 ± 86 lm) but also within the periprosthetic tissue ( Fig. 8) , indicating further adaptation of bone. This type of ''corticalization'' of the cancellous bone tissue could have contributed to the increasing pullout strength with increasing device in situ times. This appears to be a reasonable assumption since the tensile strength of cancellous bone has been shown to be less than that of cortical bone tissues (cancellous bone: 10.4 to 14.8 GPa; cortical bone: 17.3 to 26.6 GPa [28, 53] ). Moreover, although an initial increase in pullout strength was observed, the data began to reach a strength plateau region between 6 and 12 months (Fig. 6 ). This result (Fig. 8 ) further supports the observation that the range of pore size used in the POP system could facilitate the formation of cortical-type bone tissue within the pores, thereby providing a stronger interconnection between the bone and the POP device interface. These data also suggest that the P 2 coating used in this study could support direct cortical bone ingrowth into the pores. This observation may be of importance, since most human amputees will have little or no cancellous bone tissue in their residual limbs.
Our results support that immediate weightbearing did not adversely affect fixation or bone ingrowth, thereby providing provisional support for early weightbearing when porous-coated POP devices are properly fitted. These data are supported by other early weightbearing studies [14, 19, 20] . The weightbearing or mechanical stimuli of loading the device could also have played a crucial role in the rate of bone ingrowth and bone attachment strength. However, the data need to be validated in human trials.
Although the single-stage surgery was successful in our animal study, for human trials, a two-stage surgery, which has been practiced as the current clinical standard, remains the recommended approach, to allow bone and soft tissue healing before loading the POP devices. Based on our results and the principles of skeletal physiology and remodeling, one could also consider exploring limited weightbearing during the first 3 months followed by a gradually increasing weightbearing protocol during the rest of the rehabilitation period. The main result of this study provides support in an animal model for the rehabilitation protocol practiced by the German clinical group, which allows the patients to bear weight as tolerated immediately after the second surgery of the two-stage surgery protocol [1] . Design differences in the threaded device may account for the 6-month delay before the initial weightbearing protocol practiced by the Swedish clinical group led by Dr. Brånemark [12] .
